Release Date: 09/26/2016
Gasbarro’s Wines is hosting its third annual “Taste for a Cause” fundraising wine tasting to benefit the Program in Women’s Oncology at Women & Infants Hospital, a Care New England hospital.
The evening event is planned for Friday, October 21, 2016, from 6:30 to 9:30 p.m., at the Aldrich Mansion, 836 Warwick Neck Ave., Warwick. Tickets are $100 apiece. Cocktail attire is requested.
In the past two years, “Taste for a Cause” has raised more than $75,000 to support the Program in Women’s Oncology and its Integrative Care Program, which provides complementary services such as yoga, massage, guided imagery, expressive arts and acupuncture for women with cancer in the community.
“We are pleased to be working with Gasbarro’s again to raise funds for our Integrative Care Program,” says Sandra Scuncio, director of the Program. “The services we are able to provide through the generosity of such events and donations help women with cancer feel better and stronger during treatment. It’s an invaluable part of their journey.”
For more information about “Taste for a Cause” or to purchase tickets, call Stacy Hart at (401) 556-2553 or email her at firstname.lastname@example.org.
About Women & Infants Hospital
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.